BioRestorative Therapies Provides First Quarter 2024 Business Update
Provided By GlobeNewswire
Last update: May 14, 2024
MELVILLE, N.Y., May 14, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today provided an update on its business.
